Molecular subtypes of ALS are associated with differences in patient prognosis.

Eshima, Jarrett; O'Connor, Samantha A; Marschall, Ethan; Bowser, Robert; Plaisier, Christopher L; Smith, Barbara S

Eshima, Jarrett; O'Connor, Samantha A; Marschall, Ethan; Bowser, Robert; Plaisier, Christopher L; Smith, Barbara S.

Affiliation

Eshima J; School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ, 85287, USA.
O'Connor SA; School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ, 85287, USA.
Marschall E; School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ, 85287, USA.
Bowser R; Departments of Translational Neuroscience and Neurology, Barrow Neurological Institute, Phoenix, AZ, 85013, USA.
Plaisier CL; St. Joseph's Hospital and Medical Center, Department of Neurobiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Smith BS; School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ, 85287, USA.

Nat Commun ; 14(1): 95, 2023 01 06.

Article in En | MEDLINE | ID: mdl-36609402

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neurodegenerative Diseases / Amyotrophic Lateral Sclerosis / Motor Cortex Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google